Overview

BMS-741672 for Diabetic Neuropathic Pain

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether BMS-741672 improves neuropathic pain in diabetic patients.
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb